Top Ten Equity Holdings and Exposures

RNS Number : 9822Q

Polar Cap Gbl Healthcare Growth&IT

05 December 2016

 

5^th December 2016

Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")

Top Ten Equity Holdings and Sector and Geographic Exposure as at 30^th November 2016 and full Portfolio listing as at 31^st October 2016 available from company's website

Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 30^th November 2016 the top ten equity holdings and the sector and geographic breakdown were as follows:   

Top 10 Holdings	%
Merck & Co	7.7%
Pfizer	7.7%
Johnson & Johnson	6.1%
Sanofi	5.1%
GlaxoSmithKline	4.9%
Roche	4.6%
Astellas Pharma	4.0%
Merck KGaA	3.4%
Novartis	3.4%
Teva Pharmaceutical Industries	3.2%
Total	50.1%

Sector Exposure	%
Pharmaceuticals	61.2%
Healthcare Equipment	10.2%
Biotechnology	9.9%
Healthcare REITs	5.5%
Healthcare Services	4.9%
Healthcare Facilities	3.5%
Managed Healthcare	2.1%
Healthcare Supplies	1.3%
Life & Health Insurance	0.6%
Life Sciences Tools & Services	0.6%
Healthcare Distributors	0.2%
Cash	-0.1%
Total	100.0%

Geographic Exposure	%
United States	51.7%
United Kingdom	11.2%
Switzerland	8.5%
Japan	6.1%
France	5.1%
Germany	4.0%
Israel	3.2%
Australia	3.0%
Ireland	2.8%
Canada	2.0%
India	0.7%
Italy	0.6%
Denmark	0.6%
Norway	0.5%
Cash	-0.1%
Total	100%

The monthly factsheet will usually be available on the Company's website on the 10^th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.com 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.

 

END

 

 

PFUGMMGZZKVGVZM